Ocular Therapeutix, Inc. (OCUL)
8.75
-0.11
(-1.24%)
USD |
NASDAQ |
Apr 14, 16:00
8.75
0.00 (0.00%)
After-Hours: 17:37
Ocular Therapeutix Cash from Investing (TTM) : -11.88M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| EyePoint Plc | 68.58M |
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Vertex Pharmaceuticals, Inc. | -945.40M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Rhythm Pharmaceuticals, Inc. | -137.15M |